This case report details a patient presenting with an infection caused by Verruconis gallopava. Initial empiric therapy with isavuconazonium proved ineffective, highlighting a clinical failure. The diagnosis of V. gallopava infection was established, likely through microbiological methods, though specific details are not provided in the abstract. Upon transitioning the patient's treatment to posaconazole, significant clinical improvement was observed. This suggests that posaconazole may be a more effective therapeutic option for V. gallopava infections compared to isavuconazonium. Further research is needed to optimize treatment strategies for this pathogen.
Key note: Isavuconazonium may be ineffective against Verruconis gallopava, while posaconazole shows promise.